Sagimet Biosciences Inc (SGMT)
4.97
-0.10
(-1.97%)
USD |
NASDAQ |
Dec 20, 16:00
5.22
+0.25
(+5.03%)
After-Hours: 20:00
Sagimet Biosciences Total Assets (Quarterly): 174.78M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 1.073B |
| Y-mAbs Therapeutics Inc | 120.92M |
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 13.59M |
| IGC Pharma Inc | 10.37M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.092M |
| Shareholders Equity (Quarterly) | 170.68M |